• LAST PRICE
    0.0350
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0300/ 282
  • Ask / Lots
    0.0400/ 341
  • Open / Previous Close
    0.0350 / 0.0350
  • Day Range
    Low 0.0300
    High 0.0350
  • 52 Week Range
    Low 0.0250
    High 0.1050
  • Volume
    12,854
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.035
TimeVolumePHRX
09:34 ET30000.035
11:38 ET10000.035
01:24 ET10000.035
02:06 ET20000.03
03:45 ET40000.035
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaPHRX
Pharmadrug Inc
3.7M
1.2x
---
CanadaKGC
Kestrel Gold Inc
3.7M
-22.7x
---
CanadaZFR
Zephyr Minerals Ltd
3.8M
-1.6x
---
CanadaADZ
Adamera Minerals Corp
3.6M
-3.2x
---
CanadaNBRK
New Break Resources Ltd
3.7M
-3.0x
---
CanadaESAU
ESGold Corp
3.8M
-0.8x
---
As of 2024-04-12

Company Information

PharmaDrug Inc. is a Canada-based specialty pharmaceutical company. The Company is focused on the research, development and commercialization of controlled-substances and natural medicines, such as psychedelics and previously approved drugs. The Company’s subsidiary, Sairiyo Therapeutics (Sairiyo), is a biotech company that specializes in researching and reformulating established natural medicines. Sairiyo is engaged in the development of its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious diseases (including Covid-19) and rare cancers. In clinical research, Cepharanthine exhibits multiple pharmacological effects, including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is also conducting research and development (R&D) in the psychedelics space for the treatment of non-neuropsychiatric conditions.

Contact Information

Headquarters
77 King St. West, Suite 2905TORONTO, ON, Canada M5K 1H1
Phone
647-202-1824
Fax
416-765-0029

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.7M
Revenue (TTM)
$0.00
Shares Outstanding
104.6M
Pharmadrug Inc does not pay a dividend.
Beta
2.91
EPS
$0.03
Book Value
$0.17
P/E Ratio
1.2x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
2.5x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.